Live feed08:30:00·187dPRReleasevia QuantisnowCellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade GliomaByQuantisnow·Wall Street's wire, on your screen.CLRB· Cellectar Biosciences Inc.Health Care
